Literature DB >> 27937061

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?

Cornelis H van Werkhoven1.   

Abstract

Quantification of pneumococcal conjugate vaccines (PCVs) herd effects are mainly performed on invasive pneumococcal disease (IPD) but there is conflicting evidence regarding herd effects of PCVs on non-IPD pneumococcal community-acquired pneumonia. This review summarizes the available literature on herd effects of PCVs on non-IPD pneumococcal community-acquired pneumonia.

Entities:  

Keywords:  herd effects; invasive pneumococcal disease; pneumococcal conjugate vaccine; pneumococcal pneumonia

Mesh：

Substances：

Year:  2016        PMID： 27937061      PMCID： PMC5443396          DOI： 10.1080/21645515.2016.1264548

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  23 in total

1.  Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Authors:  Anneke Steens; Marianne A Riise Bergsaker; Ingeborg S Aaberge; Karin Rønning; Didrik F Vestrheim
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

2.  Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific streptococcus pneumoniae antigen in urine samples.

Authors:  Carmen L Sheppard; Timothy G Harrison; Michael D Smith; Robert C George
Journal:  J Med Microbiol       Date:  2010-09-23       Impact factor: 2.472

3.  Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia.

Authors:  Chamira Rodrigo; Thomas Bewick; Carmen Sheppard; Sonia Greenwood; Tricia M Mckeever; Caroline L Trotter; Mary Slack; Robert George; Wei Shen Lim
Journal:  Eur Respir J       Date:  2015-03-18       Impact factor: 16.671

4.  Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).

Authors:  E D G McIntosh; P Conway; J Willingham; R Hollingsworth; A Lloyd
Journal:  Vaccine       Date:  2005-02-25       Impact factor: 3.641

5.  Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Authors:  Matthew R Moore; Ruth Link-Gelles; William Schaffner; Ruth Lynfield; Catherine Lexau; Nancy M Bennett; Susan Petit; Shelley M Zansky; Lee H Harrison; Arthur Reingold; Lisa Miller; Karen Scherzinger; Ann Thomas; Monica M Farley; Elizabeth R Zell; Thomas H Taylor; Tracy Pondo; Loren Rodgers; Lesley McGee; Bernard Beall; James H Jorgensen; Cynthia G Whitney
Journal:  Lancet Infect Dis       Date:  2015-02-03       Impact factor: 25.071

6.  Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.

Authors:  Jennifer C Nelson; Michael Jackson; Onchee Yu; Cynthia G Whitney; Lora Bounds; Rachel Bittner; Ann Zavitkovsky; Lisa A Jackson
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

7.  Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.

Authors:  Zitta Barrella Harboe; Tine Dalby; Daniel M Weinberger; Thomas Benfield; Kåre Mølbak; Hans Christian Slotved; Camilla H Suppli; Helle Bossen Konradsen; Palle Valentiner-Branth
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

8.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

9.  Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status.

Authors:  Chamira Rodrigo; Thomas Bewick; Carmen Sheppard; Sonia Greenwood; Vanessa Macgregor; Caroline Trotter; Mary Slack; Robert George; Wei Shen Lim
Journal:  Thorax       Date:  2013-09-18       Impact factor: 9.139

Review 10.  Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

Authors:  Maria A Said; Hope L Johnson; Bareng A S Nonyane; Maria Deloria-Knoll; Katherine L O'Brien; Felipe Andreo; Bojana Beovic; Silvia Blanco; Wim G Boersma; David R Boulware; Jay C Butler; Jordi Carratalà; Feng-Yee Chang; Patrick G P Charles; Alejandro A Diaz; Jose Domínguez; Naomi Ehara; Henrik Endeman; Vicenç Falcó; Miquel Falguera; Kiyoyasu Fukushima; Carolina Garcia-Vidal; Daniel Genne; Igor A Guchev; Felix Gutierrez; Susanne S Hernes; Andy I M Hoepelman; Ulla Hohenthal; Niclas Johansson; Vitezslav Kolek; Roman S Kozlov; Tsai-Ling Lauderdale; Ivana Mareković; Mar Masiá; Matta A Matta; Òscar Miró; David R Murdoch; Eric Nuermberger; Richard Paolini; Rafael Perelló; Dominic Snijders; Vanda Plečko; Roger Sordé; Kristoffer Strålin; Menno M van der Eerden; Angel Vila-Corcoles; James P Watt
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240
View more
  3 in total

1.  Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants.

Authors:  Hua Zhou; Jinchun He; Bin Wu; Datian Che
Journal:  Hum Vaccin Immunother       Date:  2018-04-09       Impact factor: 3.452

Review 2.  Community-acquired pneumonia among children: the latest evidence for an updated management.

Authors:  Cristiana M Nascimento-Carvalho
Journal:  J Pediatr (Rio J)       Date:  2019-09-10       Impact factor: 2.197

3.  Pneumococcal serotypes causing non-invasive pneumonia in adults from a South Indian tertiary care hospital and the impact of the newer conjugate vaccines.

Authors:  Rosemol Varghese; Binesh Lal Yesudhason; Leena Robinson Vimala; Ayyanraj Neeravi; Kavipriya Anandhan; Pavithra Baskar; Divyaa Elangovan; Abi Manesh; Prince James; Richa Gupta; Balaji Veeraraghavan
Journal:  Access Microbiol       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.